In four common samples where we observe up-regulation of Perlecan in tumor tissue, we previously detected up-regulation of SHH, PTCH1 and GLI1 (patients 945, 1854, 921 and 1866) suggesting a complete functional pathway in these tumors. Here, HSPG2 is linked to neoplasm.